Jun 2026 (Q2 FY26) — Jul 27, 2026
OPKO Health Q2 FY26 — Pipeline Advancements and Improved Profitability
Read the full callOPKO Health earnings: last reported Mon, 27 Jul 2026, for the quarter ended Jun 2026.
Reported
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 164 | +4.3% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -4.3 | +34.0 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -8.4 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
1Y: $1.52 on 17 Oct 2025 → $1.61. High $1.73 (22 Sept 2026), low $1.1 (30 Mar 2026).
Overview
Call summaries
OPKO Health Q2 FY26 — Pipeline Advancements and Improved Profitability
Read the full callEvery analysed call
Financials
Net profit, year on year: +94% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 174 | 184 | 150 | 157 | 152 | 148 | 124 | 164 |
| Expenses | 159 | 217 | 217 | 217 | 104 | 187 | 175 | 171 |
| Operating profit | -67 | -33 | -67 | -60 | 48 | -38 | -51 | -7 |
| Operating margin | −38.7% | −18.1% | −44.8% | −38.3% | 31.7% | −25.8% | −41.1% | −4.3% |
| Other income | 34 | 68 | -6 | -103 | -7 | -9 | -10 | -6 |
| Interest | 17 | 14 | 15 | 70 | 11 | 11 | 11 | 11 |
| Profit before tax | 48 | 35 | -73 | -163 | 41 | -47 | -61 | -13 |
| Tax rate | 48.6% | 59.9% | 7.9% | 8.7% | 47.8% | 33.4% | 10.0% | 37.2% |
| Net profit | 25 | 14 | -68 | -148 | 22 | -31 | -55 | -8 |
| EPS ($ per share) | 0.04 | 0.02 | -0.10 | -0.19 | 0.03 | -0.04 | -0.07 | -0.01 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 6 | 7 | 7 | 7 | 8 | 8 | 7 | 8 |
| Reserves | -1,197 | -1,511 | -1,482 | -1,512 | -1,823 | -2,012 | -2,065 | -2,291 |
| Total liabilities | 660 | 695 | 802 | 715 | 606 | 622 | 835 | 664 |
| Fixed assets | 145 | 127 | 141 | 80 | 83 | 75 | 70 | 74 |
| Total assets | 2,451 | 2,309 | 2,473 | 2,400 | 2,167 | 2,012 | 2,200 | 1,932 |
| Line item | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | -109 | -173 | 39 | 38 | -95 | -28 | -183 | -179 |
| Cash from investing | -26 | -13 | -18 | 36 | 91 | -18 | 352 | 230 |
| Cash from financing | 141 | 175 | -35 | -10 | 23 | -11 | 184 | -118 |
| Net cash flow | 5 | -11 | -13 | 62 | 18 | -57 | 350 | -63 |
| Capital expenditure | -28 | -13 | -34 | -32 | -25 | -16 | -25 | -12 |
| Free cash flow | -137 | -185 | 6 | 6 | -120 | -44 | -208 | -191 |
37 filings between Oct 31, 2025 and Jul 24, 2026.
Purchases
$3.20M
34 purchases by 2 insiders
Sales
None
No insider sold shares.
| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| FROST PHILLIP MD ET AL | $3.19M | — | Nov 21, 2025 |
| PAGANELLI JOHN A | $11.3K | — | Mar 20, 2026 |
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Jul 24, 2026 | Logal Adam Sr. Vice President, CFO | Tax withheld | 53,266 | $65.0K |
| Jul 24, 2026 | Rubin Steven D Executive VP-Administration | Tax withheld | 53,266 | $65.0K |
| Mar 20, 2026 | PAGANELLI JOHN A Director | Purchase | 10,000 | $11.3K |
| Nov 21, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 89,375 | $118.4K |
| Nov 21, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 3,894 | $5.1K |
| Nov 21, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 191,490 | $254.7K |
| Nov 21, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 192,870 | $257.5K |
| Nov 21, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 102,371 | $133.1K |
| Nov 20, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 24,579 | $32.9K |
| Nov 20, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 119,129 | $157.3K |
| Nov 20, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 47,105 | $62.4K |
| Nov 20, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 211,948 | $281.9K |
| Nov 20, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 161,818 | $216.0K |
| Nov 20, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 1,757 | $2.4K |
| Nov 20, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 13,664 | $18.4K |
| Nov 19, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 36,325 | $46.5K |
| Nov 19, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 58,160 | $74.7K |
| Nov 19, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 300 | $387 |
| Nov 19, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 21,236 | $27.5K |
| Nov 19, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 30,082 | $39.1K |
| Nov 19, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 12,993 | $17.0K |
| Nov 19, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 66,504 | $87.1K |
| Nov 19, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 198,904 | $261.6K |
| Nov 19, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 155,496 | $205.3K |
| Nov 18, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 83,556 | $107.4K |
| Nov 18, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 410 | $510 |
| Nov 18, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 49,590 | $62.0K |
| Nov 18, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 66,635 | $83.6K |
| Nov 18, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Award | 46,700 | $58.8K |
| Nov 18, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 15,000 | $19.0K |
| Nov 18, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 1,772 | $2.3K |
| Nov 18, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 212,608 | $271.1K |
| Nov 18, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 69,728 | $89.3K |
| Nov 18, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 428 | $550 |
| Nov 18, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 1 | $1 |
| Nov 18, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 33,572 | $43.3K |
| Oct 31, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 150,000 | $213.4K |
| Aug 18, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Gift | 440,000 | $0 |
| Aug 8, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 675,000 | $891.0K |
| Apr 10, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 125,000 | $169.7K |
| Apr 8, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 125,000 | $184.7K |
| Apr 1, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 100,000 | $164.8K |
| Mar 28, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 150,000 | $254.4K |
| Mar 17, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 200,000 | $347.8K |
| Feb 28, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 67,434 | $115.3K |
| Jan 28, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 47,537 | $70.1K |
| Jan 17, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 150,000 | $220.4K |
| Jan 15, 2025 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 500,000 | $740.9K |
| Dec 13, 2024 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 125,000 | $199.4K |
| Dec 11, 2024 | FROST PHILLIP MD ET AL CEO & Chairman | Purchase | 500,000 | $781.0K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Free account. Everything above stays public.
Write why you follow OPKO HEALTH, INC. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading